157 results
Page 4 of 8
424B5
np97l4 ma18b9jbb203f
1 Sep 20
Prospectus supplement for primary offering
4:56pm
S-8
EX-99.1
io20an51zeju8
29 Jul 20
Registration of securities for employees
9:53pm
S-8
EX-5.1
wmbn ez078s013
29 Jul 20
Registration of securities for employees
9:53pm
S-8
EX-23.2
crw1vn00jai4ajwsryt
29 Jul 20
Registration of securities for employees
9:53pm
S-8
gsbhuhj q06r6goh
29 Jul 20
Registration of securities for employees
9:53pm
8-K
EX-99.1
mf05q2x8d44ih
29 Jul 20
Departure of Directors or Certain Officers
9:52pm
8-K
kx9 igsrk7h
29 Jul 20
Departure of Directors or Certain Officers
9:52pm
8-K
EX-5.1
t2080gxz1jz03ixb6a
1 Jun 20
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
6:28am
8-K
EX-10.1
t5h86i0yozg44val9
1 Jun 20
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
6:28am
8-K
EX-4.1
w6m xjqezuxx
1 Jun 20
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
6:28am
424B5
zc2gl v677q
1 Jun 20
Prospectus supplement for primary offering
6:16am